Leishmania vaccines: Old and new

Parasitology Today

Volumn 13, Issue 6, 1997, Pages 236-238

  Handman, Emanuela ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; INACTIVATED VACCINE; LEISHMANIA VACCINE; LIVE VACCINE;

ARTICLE; DRUG RESEARCH; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; LEISHMANIASIS; VACCINATION;

EID: 0030939757     PISSN: 01694758     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-4758(97)01060-0     Document Type: Article

References (27)

1. Williams, J.F. (1987) Prospects for prophylaxis of parasitism. Int. J. Parasitol. 17, 711-718
2. Struck, M-M. (1996) Vaccine R and D success rates and development times. Nat. Biotechnol. 14, 591-593
3. Mercer Report (1995) in 10th Center for Medicines Research Annual Conference Lecture, June 14, Department of Health and Human Services, Washington, DC
4. Modabber, F. (1990) Development of vaccines against leishmaniasis. Scand. J. Infect. Dis. 76, 72-78
5. Grimaldi, G.J. (1995) Meetings on vaccine studies towards the control of leishmaniasis. Mem. Inst. Oswaldo Cruz 90, 553-556
6. Locksley, R.M. and Louis, J.A. (1992) Immunology of leishmaniasis. Curr. Opin. Immunol. 4, 413-418
7. Aebischer, T., Moody, S.F. and Handman, E. (1993) Persistence of virulent Leishmania major in murine cutaneous leishmaniasis: a possible hazard for the host. Infect. Immun. 61, 220-226
8. Sharpies, C.E. et al. (1994) Immune response in healthy volunteers vaccinated with BCG plus killed leishmanial promastigotes: antibody responses to mycobacterial and leishmanial antigens. Vaccine 12, 1402-1412
9. Mendonca, S.C.F. et al. (1995) Characterization of human T lymphocyte-mediated immune responses induced by a vaccine against American tegumentary leishmaniasis. Am. J. Trop. Med. Hyg. 53, 195-201
10. Handman, E. and McConville, M.J. (1990) in New Generation Vaccines (Woodrow, C.C. and Levine, M.M., eds), pp 545-564, Marcel Dekker
11. Titus, R.G. et al. (1995) Development of a safe live Leishmania vaccine line by gene replacement. Proc. Natl. Acad. Sci. U. S. A. 92, 10267-10271
12. Xu, D. et al. (1995) Protection against Leishmania major infection in genetically susceptible BALB/c mice by GP63 delivered orally in attenuated Salmonella typhimurium (AroA-AroD-). Immunology 85, 1-7
13. McMahon-Pratt, D. et al. (1993) Recombinant vaccinia viruses expressing GP46/M-2 protect against Leishmania infection. Infect. Immun. 61, 3351-3359
14. Handman, E. et al. (1995) Protective vaccination with promastigote surface antigen 2 from Leishmania major is mediated by a TH1 type of immune response. Infect. Immun. 63, 4261-4267
15. Campos-Neto, A. et al. (1995) Cloning and expression of a Leishmania donovani gene instructed by a peptide isolated from major histocompatibility complex class II molecules of infected macrophages. J. Exp. Med. 182, 1423-1433
16. Turco, S.J. and Descoteaux, A. (1992) The lipophosphoglycan of Leishmania parasites. Annu. Rev. Microbiol. 46, 65-94
17. Kelleher, M., Bacic, A. and Handman, E. (1992) Identification of a macrophage-binding determinant on lipophosphoglycan from Leishmania major promastigotes. Proc. Natl. Acad. Sci. U. S. A. 89, 6-10
18. Kelleher, M. et al. (1994) Lipophosphoglycan blocks attachment of Leishmania major amastigotes to macrophages. Infect. Immun. 63, 43-50
19. Handman, E. and Mitchell, G.F. (1985) Immunization with Leishmania receptor for macrophages protects mice against cutaneous leishmaniasis. Proc. Natl. Acad. Sci. U. S. A. 82, 5910-5914
20. Moll, H. et al. (1989) Evidence of T-cell recognition in mice of a purified lipophosphoglycan from Leishmania major. Infect. Immun. 57, 3349-3356
21. Moll, H., Flohe, S. and Rollinghoff, M. (1995) Dendritic cells in Leishmania major-immune mice harbor persistent parasites and mediate an antigen-specific T cell immune response. Eur. J. Immunol. 25, 693-699
22. Procelli, S.A. (1996) The CD1 family: A third lineage of antigen-presenting molecules. Adv. Immunol. 59, 1-97
23. Wahren, B. (1996) Gene vaccines. Immunotechnology 2, 77-83
24. Xu, D. and Liew, F.Y. (1995) Protection against leishmaniasis by injection of DNA encoding a major surface glycoprotein, gp63 of L. major. Immunology 84, 173-176
25. Handman, E. et al. (1995) The Leishmania promastigote surface antigen 2 complex is differentially expressed during the parasite life cycle. Mol. Biochem. Parasitol. 74, 189-200
26. Fynan, E.F. et al. (1993) DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc. Natl. Acad. Sci. U. S. A. 90, 11478-11482
27. Kim, J.J. et al. (1997) In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen. J. Immunol. 158, 816-826